Radiotherapy in biochemical recurrences after surgery for prostate cancer.
A biochemical recurrence following prostatectomy is often diagnosed in relatively young and healthy men, and hence deemed very relevant concerning life, given the generally high life expectancy of these patients. Therefore, there is a need for a therapy that offers a long-term chance of cure. Following salvage radiotherapy in large multicenter series, about 45% of the patients treated are in biochemical complete remission 4 years after radiotherapy. The best chances of response are in those patients in whom none of the established risk factors, that will be discussed, are present. Given the established curative potential of salvage radiotherapy and the fact that there are no therapeutic alternatives with a realistic chance of cure, the rather moderate rates of side effects seem acceptable.
Department of Radiation Oncology and Radiotherapy, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin , Germany.
Stefan
S
Höcht
Gunnar
G
Lohm
Lutz
L
Moser
Wolfgang
W
Hinkelbein
D006801:Humans; D008297:Male; D015337:Multicenter Studies as Topic; D009364:Neoplasm Recurrence, Local / Q000532:radiotherapy*; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D016879:Salvage Therapy / Q000379:methods
D017430:Prostate-Specific Antigen